Formulation and Development of a “Pressurised Metered Dose Inhalation” beclomethasone 250 mcg. More Sandesh1,*, Mirza Javed2, Kale Nanasaheb3, Gandhi Mayur4, Chaudhari Rakesh5 1Department of Pharmaceutics, M.G.V. College of Pharmacy, Panchavati, Nashik-422003, Maharashtra, India 2Department of Quality Assurance Techniques, M.V.P. Samaj's College of Pharmacy, Near K.T.H.M. Campus, Gangapur road, Nashik-422002, Maharashtra, India 3Department of Pharmaceutical Chemistry, M.V.P. Samaj's College of Pharmacy, Near K.T.H.M. Campus, Gangapur road, Nashik-422002, Maharashtra, India 4Department of Pharmaceutics, M.V.P. Samaj's College of Pharmacy, Near K.T.H.M. Campus, Gangapur Road, Nashik-422002, Maharashtra, India 5Department of Quality Assurance Techniques, M.V.P. Samaj's College of Pharmacy, Near K.T.H.M. Campus, Gangapur Road, Nashik-422002, Maharashtra, India *Corresponding Author E-mail: moresandesh7@gmail.com
Online published on 22 October, 2014. Abstract The purpose of the present research work was to develop a robust and physicochemically stable pMDI formulation for pulmonary delivery of an Glucocorticoide, drug-Beclomethasone. The pMDI was quickly developed, providing a reliable dose in a robust, convenient and multi-dose preparation. Fortunately, at that time, metering valves capable of developing at least 100 precise spray doses had just become available. Sprays from pMDIs are self-propelled, the pressure of propellants inside the canister being used to force the spray out of the pressure of propellants inside the canister being used to force the spray out of the device via a narrow nozzle in the plastic actuator.Beclometasone dipropionate is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17 monopropionate (B-17-MP), which has potent topical antiinflammatory activity. Formulation contains Anhydrous Beclometasone Dipropionate (Micronised), Ethanol, Oleic Acid, HFA 134a(1,1,1,2 Tetrafluoro Ethane), HFA 227ea (1,1,1,2,3,3,3-Heptafluoro Propane), Propylene Glycol, PEG 300, PEG 1000, Povidone K-25. formulation was evaluated for fine particle dose, mass median aerodynamic diameter, uniformity of dose, leak test, water content, net content, no of doses. Hence it was concluded that pressurised based MDI formulation in an attempt to develop pulmonary administrable product of Beclomethasone was found to be stable and robust with desired attributes of packaging requirements. Top Keywords Baclomethasone, Hydrofluroalkane(HFA), Chronic Obstructive Pulmonary Disease (COPD), Pressurised metered dose inhaler(PMDI), Nebuliser, Propellants. Top |